ВестникНОМУС
.
Сборникматериалов
конкурса
литературных
обзоров
-2012
240
14. Boudina S. Diabetic cardiomyopathy revisited / S. Boudina, E.D. Abel //
Circulation. –2007. –Vol. 115–P. 3213–3223.
15. Chen J., Wasmund S.L., HamdanM.H. Back to the future: the role of the
autonomic nervous system in atrial fibrillation / J. Chen, S.L. Wasmund, M.H.
Hamdan // PacingClin. Electrophys. – 2006. –Vol. 29. –P. 413–421.
16. de Vos C.B. Autonomic trigger patterns and anti-arrhythmic treatment of
paroxysmal atrial fibrillation: data from the EuroHeart Survey / C.B. deVos et al. //
Eur. Heart J. 2008. –Vol. 29 –P. 632–639.
17. Dublin S. Diabetesmellitus, glycemic control and risk of atrial fibrillation /
S. Dublin // J. Gen. Intern.Med. –2010. –Vol. 25. –
Р
. 853–858.
18. Go A.S. Prevalence of diagnosed atrial fibrillation in adults: national
implications for rhythmmanagement and stroke prevention: theAnTicoagulation and
Risk Factors inAtrial Fibrillation (ATRIA) Study / A.S. Go et al. // JAMA. – 2001. –
Vol. 285. –P. 2370–2375.
19. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease. The
FraminghamStudy // JAMA. – 1979. –Vol. 241. –P. 2035–2038.
20. Kato T.What are arrhythmogenic substrates in diabetic rat atria? / T. Kato
et al. // J. Cardiovasc. Electrophysiol. – 2006. –Vol. 17–P. 890–894.
21. Konduracka E. Diabetes-specific cardiomyopathy in type 1 diabetes
mellitus: no evidence for its occurrence in the era of intensive insulin therapy / E.
Konduracka et al. // Eur. Heart J. – 2007. – Vol. 28 – P. 2465–2471.
22. Lip G. Refining clinical risk stratification for predicting stroke and
tromboembolism in atrial fibrillation using a novel risk factor-based approach the
euro heart survey on atrial fibrillation / G. Lip et al. // CHEST. – 2010.
–
Vol. 137.–
P. 263–272.
23. Nattel S.Mechanisms of atrial fibrillation: lessons from animal models. / S.
Nattel et al. // Prog. Cardiovasc. Dis. – 2005. – Vol. 48 – P. 9–28.
24. Ostgren C.J. Atrial fibrillation and its association with type 2 diabetes and
hypertension in Swedish community / C.J. Ostgren et al. // Diabetes Obes. Metab. –
2004.
–
Vol.
6
–
P.
367–374.
25. Movahed M.R. Diabetes mellitus is a strong, independent risk for atrial
fibrillation and flutter in addition to over cardiovascular disease. M.R. Movahed, M.
Hashemzadeh, M.M. Jamal // Int. J. Cardiol. – 2005. – Vol. 105 – P. 315–321.
26. OlshanskyB. Interrelationships between the autonomic nervous system and
atrial fibrillation / B. Olshansky //Prog. Cardiovasc. Dis. – 2005. –Vol. 48–P.57–78.
27. RutterM.K. Impact of glucose intolerance and insulin resistance on cardiac
structure and function: sex-related differences in the FraminghamHeart Study /M.K.
Rutter et al. // Circulation. – 2003. –Vol. 107. –
Р
. 448–454.
28. Tsang T.S.M. Atrial fibrillation: an old disease, a new epidemic / T.S.M.
Tsang, B.J. Gersh //Amer. J. ofMed. –2002. –Vol. 113. –
Р
. 432–435.
29. Vinik A.I. Diabetic cardiovascular autonomic neuropathy / A.I. Vinik, D.
Ziegler // Circulation. – 2007. –Vol. 115 –P. 387–397.
